J Ferlay

Summary

Affiliation: International Agency for Research on Cancer
Country: France

Publications

  1. ncbi Estimates of cancer incidence and mortality in Europe in 2008
    J Ferlay
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Eur J Cancer 46:765-81. 2010
  2. ncbi Worldwide burden of gynaecological cancer: the size of the problem
    R Sankaranarayanan
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon 69008, France
    Best Pract Res Clin Obstet Gynaecol 20:207-25. 2006
  3. ncbi Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Jacques Ferlay
    Section of Cancer Information, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Int J Cancer 127:2893-917. 2010
  4. ncbi Estimates of the worldwide mortality from 25 cancers in 1990
    P Pisani
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 83:18-29. 1999
  5. ncbi Estimates of the worldwide incidence of 25 major cancers in 1990
    D M Parkin
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 80:827-41. 1999
  6. ncbi Estimates of the cancer incidence and mortality in Europe in 2006
    J Ferlay
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Ann Oncol 18:581-92. 2007
  7. ncbi Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations
    C Hery
    Data Analysis and Interpretation Group, International Agency for Research on Cancer, Lyon, France
    Ann Oncol 19:1009-18. 2008
  8. ncbi Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations
    C Hery
    Data Analysis and Interpretation Group, Epidemiology Methods and Support Group, International Agency for Research on Cancer, Lyon, France
    Ann Oncol 19:1187-94. 2008
  9. ncbi Estimates of cancer incidence and mortality in Europe in 1995
    F Bray
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Eur J Cancer 38:99-166. 2002
  10. ncbi Prostate cancer incidence and mortality trends in 37 European countries: an overview
    F Bray
    Cancer Information Section, International Agency for Research on Cancer, Lyon, France
    Eur J Cancer 46:3040-52. 2010

Detail Information

Publications13

  1. ncbi Estimates of cancer incidence and mortality in Europe in 2008
    J Ferlay
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Eur J Cancer 46:765-81. 2010
    ..9%). The most common causes of death from cancer were lung cancer (342,000 deaths, 19.9% of the total), colorectal cancer (212,000 deaths, 12.3%), breast cancer (129,000, 7.5%) and stomach cancer (117,000, 6.8%)...
  2. ncbi Worldwide burden of gynaecological cancer: the size of the problem
    R Sankaranarayanan
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon 69008, France
    Best Pract Res Clin Obstet Gynaecol 20:207-25. 2006
    ..Political will and advocacy to invest in healthcare infrastructure and human resources to improve service delivery and accessibility are vital to reduce the current burden in low- and medium-resource countries...
  3. ncbi Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Jacques Ferlay
    Section of Cancer Information, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Int J Cancer 127:2893-917. 2010
    ..7%) and liver cancer (696,000 deaths, 9.2%). Cancer is neither rare anywhere in the world, nor mainly confined to high-resource countries. Striking differences in the patterns of cancer from region to region are observed...
  4. ncbi Estimates of the worldwide mortality from 25 cancers in 1990
    P Pisani
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 83:18-29. 1999
    ..Our results indicate the potential impact of preventive practices. It is estimated that 20% of all cancer deaths (1 million) could be prevented by eliminating tobacco smoking. Infectious agents account for a further 16% of deaths...
  5. ncbi Estimates of the worldwide incidence of 25 major cancers in 1990
    D M Parkin
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 80:827-41. 1999
    ..The implications of these patterns for cancer control, and specifically prevention, are discussed. Tobacco smoking and chewing are almost certainly the major preventable causes of cancer today...
  6. ncbi Estimates of the cancer incidence and mortality in Europe in 2006
    J Ferlay
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Ann Oncol 18:581-92. 2007
    ..Monitoring the evolution of the cancer burden in Europe is of great value. Estimates of the cancer burden in Europe have been published for 2004 and estimates are now being presented for cancer incidence and mortality in Europe for 2006...
  7. ncbi Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations
    C Hery
    Data Analysis and Interpretation Group, International Agency for Research on Cancer, Lyon, France
    Ann Oncol 19:1009-18. 2008
    ..Mammography screening and menopause hormone therapy is essentially offered to women 50-69 years old...
  8. ncbi Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations
    C Hery
    Data Analysis and Interpretation Group, Epidemiology Methods and Support Group, International Agency for Research on Cancer, Lyon, France
    Ann Oncol 19:1187-94. 2008
    ..Since 1985 considerable changes have taken place in the early detection and treatment of breast cancer. We quantified breast cancer trends for 35 countries with populations mainly of European ancestry...
  9. ncbi Estimates of cancer incidence and mortality in Europe in 1995
    F Bray
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Eur J Cancer 38:99-166. 2002
    ..In particular, there is a clear urgency to combat the ongoing tobacco epidemic, now prevalent in much of Europe, particularly in the Eastern countries...
  10. ncbi Prostate cancer incidence and mortality trends in 37 European countries: an overview
    F Bray
    Cancer Information Section, International Agency for Research on Cancer, Lyon, France
    Eur J Cancer 46:3040-52. 2010
    ..The increase in mortality observed in the Baltic region and in several Central and Eastern European countries appear to reflect a real increase in risk and requires further monitoring...
  11. ncbi Global cancer statistics, 2002
    D Max Parkin
    Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France
    CA Cancer J Clin 55:74-108. 2005
    ..Most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention...
  12. ncbi Cancer incidence and mortality in Europe, 2004
    P Boyle
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Ann Oncol 16:481-8. 2005
    ..Those data that are available generally refer to the mid-1990s and are of limited use for cancer control planning. We present estimates of the cancer burden in Europe in 2004, including data for the (25 Member States) European Union...
  13. ncbi Cancer deaths in India: is the model-based approach valid?
    P C Gupta
    International Agency for Research on Cancer, Lyon, France
    Bull World Health Organ 72:943-4. 1994
    ..The model-based approach is therefore, at least in the case of India, incorrect. Established practice is to use real data to validate theoretical models, not to reject the data if apparently the model does not fit...